Similar articles

• A cost-minimization analysis of dexmedetomidine compared with midazolam for long-term sedation in the intensive care unit.

  Dasta JF, Kane-Gill SL, Pencina M, Shehabi Y, Bokesch PM, Wisemandle W, Riker RR. Dasta JF, et al. Crit Care Med. 2010 Feb;38(2):497-503. doi: 10.1097/CCM.0b013e3181bc81c9. Crit Care Med. 2010. PMID: 19789442 Clinical Trial.
• Dexmedetomidine versus standard care sedation with propofol or midazolam in intensive care: an economic evaluation.

  Turunen H, Jakob SM, Ruokonen E, Kaukonen KM, Sarapohja T, Apajasalo M, Takala J. Turunen H, et al. Crit Care. 2015 Feb 19;19(1):67. doi: 10.1186/s13054-015-0787-y. Crit Care. 2015. PMID: 25887576 Free PMC article.
• Addition of dexmedetomidine to standard sedation regimens after cardiac surgery: an outcomes analysis.

  Dasta JF, Jacobi J, Sesti AM, McLaughlin TP. Dasta JF, et al. Pharmacotherapy. 2006 Jun;26(6):798-805. doi: 10.1592/phco.26.6.798. Pharmacotherapy. 2006. PMID: 16716133
• Pharmacoeconomics of sedation in the ICU.

  Dasta JF, Kane-Gill S. Dasta JF, et al. Crit Care Clin. 2009 Jul;25(3):571-83, ix. doi: 10.1016/j.ccc.2009.03.002. Crit Care Clin. 2009. PMID: 19576531 Review.
• An updated focused review of dexmedetomidine in adults.

  Gerlach AT, Murphy CV, Dasta JF. Gerlach AT, et al. Ann Pharmacother. 2009 Dec;43(12):2064-74. doi: 10.1345/aph.1M310. Ann Pharmacother. 2009. PMID: 19934395 Review.